INTRODUCTION
============

*In vitro* maturation (IVM) and *in vitro* fertilization (IVF) of porcine oocytes have been extensively investigated. Oocyte maturation is a critical step in *in vitro* production systems because it influences oocyte quality, which subsequently affects embryonic development, fetal development, and even the health of the offspring ([@b6-ajas-26-4-501-7]). However, oocytes that mature *in vitro* have decreased developmental competence when compared to oocytes matured *in vivo*, indicating that IVM systems are still suboptimal. Therefore, optimization of currently available maturation medium is important to increase the efficiency of IVM systems.

Amino acids are included in the majority of culture media for both oocyte maturation and embryonic culture because they serve a variety of physiological functions including protein and nucleotide synthesis ([@b7-ajas-26-4-501-7]; [@b1-ajas-26-4-501-7]), provision of energy sources ([@b10-ajas-26-4-501-7]), protection against osmotic shock ([@b17-ajas-26-4-501-7]) with oxidative stress ([@b21-ajas-26-4-501-7]), and regulation of pH ([@b5-ajas-26-4-501-7]). Spontaneous degradation and catabolism of amino acids, particularly glutamine (Gln), can result in the production of ammonia ([@b9-ajas-26-4-501-7]), which is toxic to living cells both *in vivo* ([@b27-ajas-26-4-501-7]) and *in vitro* ([@b42-ajas-26-4-501-7]). The presence of ammonia in culture medium results in a reduction of intracellular pH, depression of oxidative phosphorylation ([@b20-ajas-26-4-501-7]), decreased blastocyst cell numbers ([@b9-ajas-26-4-501-7]), increased cellular apoptosis, perturbation of *Slc2a3* expression and glucose uptake ([@b44-ajas-26-4-501-7]), and eventually altered fetal development and growth rates ([@b30-ajas-26-4-501-7]) as well as fetal exencephaly ([@b18-ajas-26-4-501-7]).

The toxic effects of Gln can be avoided by adding dipeptides into the culture media for direct use by mammalian cells *in vitro* ([@b4-ajas-26-4-501-7]). It has been suggested that Gln could be replaced with L-alanyl-L-glutamine (AlnGln) and L-glycyl-L-glutamine (GlyGln) to achieve an increased level of embryonic deployment in mice ([@b2-ajas-26-4-501-7]). We previously reported that the accumulation of ammonia in the medium could be reduced by supplementation with seleon L-methionine (SeMet) and SeMet+Vitamin-E ([@b36-ajas-26-4-501-7]). Dipeptides play an important role in oocyte maturation ([@b34-ajas-26-4-501-7]) and the porcine sperm acrosome reaction ([@b35-ajas-26-4-501-7]). Although a number of studies have shown the importance of dipeptides in embryo development, the direct effects of GlyGln and AlaGln on the accumulation of ammonia in culture media and *in vitro* porcine embryo development have not yet been definitively demonstrated. Therefore, this study was conducted to investigate the effects of Gln, glutamic acid (Glu), GlyGln and AlaGln on embryo development and accumulation of ammonia in the medium during *in vitro* maturation, fertilization, and development of porcine embryos.

MATERIAL AND METHODS
====================

Chemicals
---------

Radioactive ^14^C(U)-glucose was purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO, USA). Gln, Glu, GlyGln, AlaGln and all other chemicals were of analytical grade and purchased from Nacalai Tesque (Kyoto, Japan), unless otherwise indicated.

Oocyte recovery and *in vitro* maturation
-----------------------------------------

Ovaries were collected from gilts (Landrace, Large White and Duroc) at a local slaughterhouse and transported to the laboratory in physiological saline supplemented with 100 IU/ml Penicillin G and 100 mg/ml Streptomycin sulfate at 30 to 35°C within 1 to 3 h of collection. Cumulus-oocyte complexes (COCs) from follicles 3 to 6 mm in diameter were aspirated using an 18-gauge needle attached to a 10 ml disposable syringe. Intact COCs were selected using mouth pipettes and washed three times in HEPES-buffered North Caroline State University medium in glutamine and glucose-free (NCSU)-23 supplemented with 0.3% bovine serum albumin (BSA). Washed COCs were transferred to IVM medium consisting of modified Tissue culture medium (mTCM)-199 supplemented with 10 ng/ml epidermal growth factor (EGF), 4 IU/ml pregnant mare serum gonadotropin (PMSG; Sankyo Zoki, Tokyo, Japan) and human chorionic gonadotropin (hCG; Sankyo Zoki, Tokyo, Japan), and 10% (v/v) porcine follicular fluid (pFF). The pFF was collected from antral follicles of prepubescent gilts, centrifuged at 1,600×g for 30 min and filtered through both 1.2 and 0.45-μm syringe filters (Toyo Roshi Kaisha, Ltd., Tokyo, Japan). The filtered pFF was stored in aliquots at −20°C for further use. Fifty COCs in 500 μl of IVM medium were cultured at 39°C under 5% CO~2~ in air. After culturing for 22 h, COCs were washed three times and cultured in PMSG and hCG-free mTCM-199 medium for an additional 22 h at 39°C under 5% CO~2~ in air.

Sperm preparation and *in vitro* fertilization
----------------------------------------------

Ejaculated sperm were obtained from Duroc boars and diluted according to the method described by [@b14-ajas-26-4-501-7]. After being washed three times by centrifugation at 900×g for 5 min each, the sperm pellet was resuspended in *in vitro* fertilization medium, which consisted of modified Tyrode's albumin lactate pyruvate (mTALP) medium ([@b25-ajas-26-4-501-7]) containing 3 mg/ml BSA and 2 mM caffeine to give a final concentration of 2×10^6^ spermatozoa/ml ([@b34-ajas-26-4-501-7]). The oocytes and spermatozoa were co-cultured for 6 h at 39°C in an atmosphere of 5% CO~2~ in air. At 44 h of maturation, oocytes were freed from cumulus cells by repeated pipetting in 0.1% hyaluronidase in mTCM-199 medium and then washed three times with pre-equilibrated mTALP. After washing, 20 to 25 oocytes were placed in 45 μl drops of the mTALP (fertilizing drop). The samples were then covered with pre-warmed paraffin oil and 5 μl of sperm suspension was added to each fertilization drop to give a final sperm concentration of 2×10^6^ sperm/ml. After co-incubation of gametes for 6 h, the presumptive zygotes were washed and transferred into culture (IVC) medium.

Embryo culture
--------------

After IVF, COCs were washed several times in a fertilization drop to remove spermatozoa loosely attached to inseminated oocytes and then washed a final time in glutamine and glucose-free modified North Carolina State University (mNCSU)-23 ([@b26-ajas-26-4-501-7]) medium containing 0.5 mM sodium pyruvate, 5 mM sodium lactate, and 0.4% BSA (A-6003, fraction V). Ten to fifteen putative zygotes were then freed from cumulus cells and transferred to a 30 μl microdrop of culture medium covered with warm mineral oil. Embryos were cultured for up to 168 h after IVF in a humidified atmosphere of 39°C and 5% CO~2~ in air without any replacement with fresh medium ([@b12-ajas-26-4-501-7]).

Assessment of meiotic maturation, sperm penetration and embryo cell number
--------------------------------------------------------------------------

Oocyte maturation, fertilization, cleavage and blastocyst formation and blastomere number in blastocysts were examined at 44 h after IVM and at 12, 48, and 168 h after IVF, respectively. At the time of examination, oocytes or blastocysts were mounted on a glass slide and fixed for 10 min in 25% (v/v) acetic acid in ethanol. Fixation was carried out on a 33.8°C warm plate for the removal of lipids within 10 min. The samples were then stained with 1% (w/v) orcein in 45% (v/v) acetic acid solution and examined under a phase-contrast microscope (IX-50, Olympus, Tokyo, Japan) at 400×. The meiotic stage of the oocytes was assessed according to the methods described by [@b13-ajas-26-4-501-7] and oocytes at the metaphase II (MII) stage were regarded as mature. Oocytes were considered to be penetrated when they contained one or more swollen sperm heads or male pronuclei with corresponding sperm tails.

Differential staining
---------------------

The quality of blastocysts was assessed by differential staining of the inner cell mass (ICM) and trophectoderm (TE) cells according to the modified staining procedure described by [@b38-ajas-26-4-501-7]. Briefly, hatched blastocysts were left untreated, and unhatched blastocysts were treated with 0.25% pronase (w/v, Sigma-Aldrich, St. Louis, MO, USA) for 5 min to dissolve the zonae pellucidae. After rinsing in mNCSU-23 medium, zona-free blastocysts were stained with 0.01% (w/v) bisbenzimide for 1 h. The blastocysts were then rinsed in mNCSU-23 medium again and treated with 0.04% (v/v) Triton X-100 (Sigma-Aldrich) for 3 min followed by treatment with 0.005% (w/v) propidium iodide (Sigma-Aldrich) for 10 min. After another rinse in mNCSU-23 medium, stained blastocysts were mounted on glass slides under a cover slip and examined with an inverted microscope (Nikon Corp., Tokyo, Japan) equipped with epifluorescence. The ICM nuclei labeled with bisbenzimide appeared blue, and the TE cell nuclei labeled with both bisbenzimide and propidium iodide appeared pink. Blastocysts without dual staining were excluded from the study ([@b38-ajas-26-4-501-7]).

Incorporation and oxidation of radiolabeled glucose
---------------------------------------------------

The radioactive substrates, ^14^C(U)-glucose (specific activity: 185 MBq/mM), were produced as described in our previous study ([@b40-ajas-26-4-501-7]). All scintillation vials and three blanks for each group were filled with 5 ml of cocktail and then set in a liquid scintillation counter (LS-6500, Beckman-Coulter, CA, USA) to determine the levels of radioactivity. This experiment was conducted five times to improve its accuracy. All values of incorporation and oxidation are expressed directly as counts per min (cpm) ([@b39-ajas-26-4-501-7]).

Ammonia assay
-------------

The ammonia concentrations in the medium were assessed using the Berthelot-indophenol method as previously described ([@b37-ajas-26-4-501-7]). This method was further used to analyze the maturation at the MII stage within 44 h, fertilization for 6 h and culture of oocytes, cleavage to the 2-cell stage at 48 h and the blastocyst stage at 168 h. After completion of the stages mentioned above, 50 μl of the culture medium was immediately sampled to measure the concentration of ammonia. This procedure was performed five times for each analysis. A calibration curve in the range of 0 to 0.40 mM ammonia was run for each experiment and the mean correlation coefficient for the calibration curves of five experiments was 0.995.

Experimental design
-------------------

In this study, various combinations of the optimal concentration of Gln, Glu, GlyGln and AlaGln were used to examine the effects of mTCM-199 on IVM for 44 h, the effects of mTALP on IVF for 6 h and the effects of mNCSU-23 on IVC for 168 h. Finally, the incorporation and oxidation of the ^14^C(U)-glucose, accumulation of ammonia after IVM, IVF and IVC and number of cells within blastocysts were investigated. After supplementation with all chemicals, the pH and osmolarity of each media was adjusted to 7.4 and 270 mOsm.

Statistical analysis
--------------------

Oocytes were randomly distributed within each experimental group, and each experiment was repeated five times. Arcsine-transformed percentages of replications for rates of maturation, fertilization and embryonic development ([@b31-ajas-26-4-501-7]) and data for the mean number of cells per blastocyst were subjected to ANOVA using the GLM procedures of the Statistical Analysis System (SAS Institute, Inc., Cary, NC, USA) and then analyzed by the Duncan's multiple range test. A p\<0.05 was considered to indicate statistical significance.

RESULTS
=======

The percentage of oocyte development to the MII stage, monospermic fertilization and male pronuclear formation increased significantly (p\<0.05) when oocytes were treated with AlaGln, GlyGln and AlaGln+GlyGln when compared to the control and other treatments groups ([Table 1](#t1-ajas-26-4-501-7){ref-type="table"}). Among this specific treatment subset, the percentage of oocytes developing to the MII stage, monospermic fertilization and male pronuclear formation increased significantly (p\<0.05) when oocytes were treated with AlaGln+GlyGln when compared to treatment with AlaGln and GlyGln. However, there was no significant difference between treatment with Gln, Glu and Gln+Glu in terms of the rates of maturation and fertilization.

The incorporation and oxidation rates of ^14^C(U)-glucose were significantly higher (p\<0.05) in oocytes treated with AlaGln+GlyGln than in those of the control group during maturation and fertilization ([Table 2](#t2-ajas-26-4-501-7){ref-type="table"}); therefore, there was no significant difference between treatment with Gln, Glu and Gln+Glu when compared with the control group. The accumulation of ammonia in the medium was significantly reduced (p\<0.05) after the addition of AlaGln+GlyGln, with the exception of Gln, Glu and Gln+Glu, when compared with the other treatments groups during maturation and fertilization. The development rates for the 2 to 4 cell, 8 to 16 cell, morula, and blastocyst stages were higher when embryos were treated with AlaGln, GlyGln and AlaGln+GlyGln. In addition, the development rates of the 2 to 4 cell, 8 to 16 cell, morula and blastocyst stages were higher for samples treated with AlaGln+GlyGln than with AlaGln and GlyGln. Gln, Glu and Gln+Glu had no significant (p\<0.05) effect on 2 to 4 cell, 8 to 16 cell, morula and blastocyst development when compared to the control group ([Table 3](#t3-ajas-26-4-501-7){ref-type="table"}). The incorporation and oxidation rates of ^14^C (U)-glucose were higher (p\<0.05) in embryos treated with AlaGln+GlyGln at the 2-cell and blastocyst stages than in the control group. The accumulation of ammonia in the culture medium was significantly reduced (p\<0.05) in the presence of AlaGln, GlyGln and AlaGln+GlyGln when compared with those of the other treatment groups. Specifically, treatment with AlaGln+GlyGln had the largest impact on reducing the accumulation of ammonia in the 2-cell and blastocyst stages when compared with those of the control group ([Table 4](#t4-ajas-26-4-501-7){ref-type="table"}). Moreover, the numbers of ICM and TE cells in the AlaGln, GlyGln and AlaGln+GlyGln treatment groups were found to be significantly higher (p\<0.05) than those in the control group. Finally, more ICM and TE cells were observed in the AlaGln+GlyGln treated embryos than in those in the control group and all other treatment groups ([Table 5](#t5-ajas-26-4-501-7){ref-type="table"}).

DISCUSSION
==========

We previously reported that porcine oocyte maturation was adversely affected when ≥300 μM exogenous ammonia was added to the maturation medium ([@b34-ajas-26-4-501-7]). Interestingly, follicular fluid concentrations of ammonia in porcine ranged from 350 μM in small follicles (diameter ≤2mm) to 170 μM in large follicles (diameter: 5 to 6 mm) ([@b37-ajas-26-4-501-7]). These results indicate that the apparent threshold concentration of ammonia toxicity for oocytes from porcine under *in vitro* conditions (200 to 300 μM) is greater than the levels oocytes are exposed to as a large follicle during nuclear maturation (170 μM).

The present findings demonstrate that the concentrations of ammonia in the culture media during the maturation (120 μM), fertilization (110 μM), 2-cell (70 μM) and blastocyst stages (100 μM) were significantly reduced when treated with AlaGln+GlyGln relative to the levels in other treatment groups. The optimal concentration of amino acids and dipeptides used in the present study was similar to the concentration used in studies examining porcine oocytes and sperm ([@b34-ajas-26-4-501-7]; [@b35-ajas-26-4-501-7]). These results indicate that sensitivity to ammonia is dependent on the developmental stage of the oocyte or embryo, and may be related to the presence of cumulus cells. In contrast, *in vitro* exposure of bovine oocytes to ammonia concentrations up to 400 μM for 24 h IVM did not adversely influence oocyte nuclear maturation, even though concentrations of ammonia in bovine follicular fluid range from 366±51 μM in small follicles (diameter≤1 mm) to 33±10 μM in large follicles (diameter: 10 to 15 mm) ([@b11-ajas-26-4-501-7]). [@b43-ajas-26-4-501-7] proposed that the production of ammonia during *in vitro* oocyte maturation has detrimental effects on the nuclear progression to MII. In addition, the presence of ammonia during embryo culture negatively influences subsequent embryonic development, although parthenogenetic activation embryos appear to be more sensitive to the negative effects of ammonia during oocyte maturation than IVF embryos. In our previous study, the presence of 300 μM ammonia in the IVM and IVF medium modified North Carolina State University (mNCSU)-37 of oocytes treated with combinations of dipeptides including AlaGln and GlyGln in the media were found to be more stable and effective than treatment with individual amino acids at reducing the accumulation of ammonia and to increase the rate of porcine oocyte MII and monospermic fertilization *in vitro* ([@b34-ajas-26-4-501-7]). These results suggest that during *in vitro* maturation, bovine oocytes have a greater tolerance of high physiological concentrations of ammonia than porcine oocytes. During IVM, cumulus cells are considered to be of vital importance to the success of oocyte maturation ([@b33-ajas-26-4-501-7]). *In vitro* growth and metabolism of cumulus cells is altered by concentrations of ammonia similar to those measured in follicular fluid, and the ability of these cumulus cells to support *in vitro* maturation of oocytes is impaired ([@b28-ajas-26-4-501-7]). Alternatively, cumulus cells may reduce the amount of ammonia the oocyte is directly exposed to by detoxifying the ammonia in the medium or preventing transport to the oocyte via gap junctions. Our data strongly suggest that the addition of AlaGln+GlyGln has the greatest effect on MII, monospermic fertilization and male pronuclear formation, maturation and fertilization in mTCM-199 and mTALP media.

Amino acids support normal preimplantation development *in vivo* as evidenced by *in vitro* studies. Spontaneous degradation and breakdown of amino acids results in the formation of pyrrolidone carbonic acid and potentially harmful ammonia. Ammonia toxicity for living cells is well recognized *in vitro* and *in vivo*. Specifically, increased levels of ammonia decrease the pH and increase the osmolarity, leading to a progressive loss of sperm motility ([@b15-ajas-26-4-501-7]) and decreased the rates of porcine oocyte MII and monospermic fertilization *in vitro* ([@b34-ajas-26-4-501-7]). Our results demonstrate that the accumulation of ammonia was reduced by treatment with AlaGln+GlyGln when compared with those of the other treatment groups. We found that treatment with AlaGln+GlyGln dipeptides may play an important role in reducing the accumulation of ammonia in the culture medium and increase the rates of oocyte maturation, fertilization, and development into blastocysts. Our previous study ([@b34-ajas-26-4-501-7]) confirmed the effects of treatment with AlaGln and GlyGln on reducing the accumulation of ammonia in porcine IVM and IVF medium containing exogenous ammonia (300 μM), and that these treatments led to an increased rate of nuclear maturation and mono-spermic fertilization in mNCSU-37 media. When compared to the results reported for bovine oocytes, porcine oocytes were found to be more sensitive to the ammonia concentration, as indicated by blastocyst formation. Oocytes of pigs had decreased blastocyst development when induced to a mature state with 200 μM ammonia ([@b43-ajas-26-4-501-7]). However, it is possible that ammonia accumulated in the oocytes during IVM via Na^+^/K^+^-ATPase or Na^+^/K^+^ 2Cl co-transporter ([@b22-ajas-26-4-501-7]).

Several studies have demonstrated the impact of glucose metabolism in mammalian preimplantation embryos, and nutrient uptake studies of porcine embryos have shown that the embryos consume glucose and produce lactate at all stages of development. Therefore, glucose-containing media is commonly used to produce porcine embryos *in vitro* ([@b8-ajas-26-4-501-7]). The incorporation and oxidation of glucose serve as indicators of the vitality of oocytes and the resulting eggs ([@b40-ajas-26-4-501-7]). In this study, the incorporation and oxidation rates of ^14^C(U)-glucose were significantly higher in AlaGln+GlyGln treated oocytes than in the control group during maturation, fertilization, and the 2-cell and blastocyst stages, which was in agreement with the results of our previous study ([@b36-ajas-26-4-501-7]). We reported that the combination of selenium and vitamin E in comparison with single supplementation improves porcine embryos, which suggests that the incorporation and oxidation rates of ^14^C(U)-glucose were higher in embryos treated with SeMet and SeMet+Vitamin-E at the 2-cell and blastocyst stages. [@b9-ajas-26-4-501-7] proposed that ammonia may adversely affect the developing embryo by decreasing the concentration of α-ketoglutarate by converting it to Gln, thereby reducing the influx through the tricarboxylic acid cycle and depleting ATP production in embryonic cells. Therefore, high ammonia in the culture media at the time of compaction and blastulation may reduce the availability of ATP for embryonic cells during a stage of development when energy demands by the embryo are high, resulting in increased degenerate ova and decreased blastocyst stages. Furthermore, pyruvate may be used as an ammonia sink by transamination to alanine in early embryos ([@b24-ajas-26-4-501-7]). Gln can also dispose of ammonia by transfer into Gln in blastocysts, but only in the absence of pyruvate available for transamination to alanine ([@b24-ajas-26-4-501-7]). Gln is the most volatile amino acid and is easily degraded in culture medium, resulting in generation of ammonia ([@b19-ajas-26-4-501-7]). The amount of ammonia produced by medium containing Gln incubated at 37°C for 24 h is sufficient to inhibit embryo development ([@b19-ajas-26-4-501-7]; [@b24-ajas-26-4-501-7]; [@b41-ajas-26-4-501-7]). One method of reducing toxic ammonia build up is substituting Gln with more stable dipeptides including AlaGln and GlyGln. Substitution of AlnGln for Gln in mouse embryo culture medium results in significantly decreased ammonia concentrations ([@b19-ajas-26-4-501-7]). This is also an effective way to optimize porcine oocyte IVM, IVF and IVC systems. These results are in agreement with those of other research groups ([@b2-ajas-26-4-501-7]). GlyGln has been used to replace Gln in culture medium and is advantageous to mouse embryonic development ([@b32-ajas-26-4-501-7]). Our findings suggested that AlaGln+GlyGln might protect against the oxidative damage caused by ammonia production. To the best of our knowledge, this is the first study demonstrating that the addition of AlaGln+GlyGln to porcine embryo culture increases the 2 to 4 cell, 8 to 16 cell, morula and blastocyst stages in a defined, Gln-free mNCSU-23 medium. However, the significant increase in the number of ICM and TE cells produced by AlaGln+GlyGln suggests that alanine and glycine produced the primary effect via an unknown mechanism. A routine supplementation of Gln with the more stable form of AlaGln or GlyGln in the culture medium markedly reduced the accumulation of ammonia during blastocyst formation in mice ([@b4-ajas-26-4-501-7]), which is in agreement with the results of the present study. Together, these findings confirm that AlaGln+GlyGln dipeptides are able to inhibit the accumulation of ammonia in culture medium. When tissue is present, ammonia also forms due to the metabolism of Gln ([@b23-ajas-26-4-501-7]) and other metabolites (metabolic ammonia). The accumulation of ammonia and 2-pyrrolidone-5-carboxylic acid can be reduced by substituting more stable dipeptides that can also be utilized by cells *in vitro* ([@b4-ajas-26-4-501-7]). It has been suggested that these dipeptides are first hydrolyzed to extracellular peptidase secreted by the cultured cells ([@b3-ajas-26-4-501-7]). [@b29-ajas-26-4-501-7] used AlnGln or GlyGln to prevent the deleterious effect of autoclaving RPMI medium, which contains Gln, on the growth of K562 cells. Since their study, these Gln-containing dipeptides have been used to replace Gln in media employed in the culture of other cell types ([@b3-ajas-26-4-501-7]).

In conclusion, the results of our study demonstrate that dipeptides are involved in modulation of porcine oocyte maturation, fertilization and embryo development. The combination of AlaGln+GlyGln may be involved in reducing the accumulation of ammonia, and consequently in increasing the rates of maturation, fertilization, embryo development, and the glucose uptake with the treatment in the porcine embryo. Elsewhere, we have presented evidence that replacing Gln with AlaGln and/or GlyGln, (2.0 mM) which is now being added to several commercial media formulations, can inhibit the accumulation of ammonia in embryo development culture media.
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###### 

Effects of glutamine (Gln), glutamic acid (Glu), L-alayl-L-glutamine (AlaGln), L-glycyl-L-glutamine (GlyGln) and their combinations on the percentage of maturation and fertilization of porcine oocytes

  Treatment                    Maturation (%)[^1^](#tfn3-ajas-26-4-501-7){ref-type="table-fn"}   Fertilization (%)[^1^](#tfn3-ajas-26-4-501-7){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                  
  ---------------------------- ----------------------------------------------------------------- -------------------------------------------------------------------- --------------------------------------------------------------------- ---------------------------------------------------------------------- ----- --------------------------------------------------------------------- --------------------------------------------------------------------- ---------------------------------------------------------------------
  Control (0)                  221                                                               \(27\) 12.21±1.33[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(34\) 15.38±0.79[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(160\) 72.39±1.29[^d^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    185   \(120\) 65.00±2.31[^d^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(102\) 55.33±1.93[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(80\) 43.16±1.65[^de^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}
  Gln (1.0 mM)                 210                                                               \(35\) 16.58±0.33[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(28\) 13.27±0.71[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(147\) 69.66±1.32[^ef^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   172   \(107\) 62.46±1.32[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(99\) 57.70±3.10[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(78\) 45.16±1.82[^d^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}
  Glu (1.0 mM)                 198                                                               \(36\) 17.91±1.25[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(25\) 12.43±0.88[^bc^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(137\) 68.15±1.50[^f^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    198   \(115\) 58.16±1.85[^f^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(123\) 62.33±1.33[^d^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(81\) 41.26±1.30[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln (2.0 mM)              230                                                               \(15\) 6.52±1.47[^c^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(26\) 11.30±1.42[^cd^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(189\) 82.17±1.40[^c^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    122   \(87\) 71.37±2.00[^c^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(80\) 65.30±2.43[^c^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(92\) 75.33±2.00[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}
  GlyGln (2.0 mM)              200                                                               \(8\) 3.98±0.65[^d^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}     \(21\) 10.44±0.85[^de^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(171\) 85.07±1.70[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    135   \(100\) 74.36±2.30[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(92\) 68.63±1.85[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(102\) 75.66±1.20[^b^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln+GlyGln (2.0+2.0 mM)   196                                                               \(5\) 3.59±1.53[^d^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}     \(20\) 10.36±1.38[^bc^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(171\) 88.60±1.13[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    155   \(120\) 77.33±1.20[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(110\) 71.00±1.60[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(124\) 80.16±3.00[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}
  Gln+Glu (1.0+1.0 mM)         204                                                               \(38\) 18.26±0.95[^a^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}   \(20\) 9.61±1.15[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}     \(146\) 70.19±1.30[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    145   \(90\) 62.20±1.65[^e^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(73\) 50.90±1.60[^f^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}    \(73\) 50.17±3.00[^c^](#tfn1-ajas-26-4-501-7){ref-type="table-fn"}

Within a column, values with different letters (a--f) are significantly different (p\<0.05).

n: number of oocytes, five replicates.

Percentage of the number of oocytes.

Penetrated oocytes with one first and one second polar body.

With both single male pronuclear (MPN) and female pronuclei.

MPN indicates male pronucleus or pronuclei.

###### 

The rates of incorporation and oxidation of ^14^C(U)-glucose and the accumulation of ammonia upon treatment with glutamine (Gln), glutamic acid (Glu), L-alayl-L-glutamine (AlaGln), L-glycyl-L-glutamine (GlyGln) and their combinations on the maturation and fertilization of porcine oocytes

  Treatment n (25)             Incorporation of ^14^C(U)-glucose (cpm/oocyte)[^3^](#tfn11-ajas-26-4-501-7){ref-type="table-fn"}   Oxidation of ^14^C(U)-glucose (cpm/oocyte)[^3^](#tfn11-ajas-26-4-501-7){ref-type="table-fn"}   Ammonia concentration (μM)[^3^](#tfn11-ajas-26-4-501-7){ref-type="table-fn"}                                                                                                                                     
  ---------------------------- -------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------- ---------------------------------------------------------------- ----------------------------------------------------------------
  Control (0)                  2,040.00±286.88[^de^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                  1,631.66±222.89[^d^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                               173.33±12.41[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  161.00±23.39[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    190.00±11.56[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    170.00±11.55[^ab^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}
  Gln (1.0 mM)                 2,315.67±176.40[^d^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                   1,853.67±334.34[^d^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                               180.33±34.64[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  181.67±38.43[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    143.33±29.06[^ab^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}   180.00±17.32[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}
  Glu (1.0 mM)                 2,142.33±182.01[^de^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                  1,740.33±285.83[^d^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                               174.66±10.41[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  163.00±24.54[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    180.00±17.64[^ab^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}   166.66±8.82[^ab^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln (2.0 mM)              3,920.00±171.22[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                   3,844.67±109.27[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                               303.67±12.13[^b^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  321.66±28.29[^b^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    130.00±11.56[^bc^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}   140.00±11.55[^bc^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}
  GlyGln (2.0 mM)              4,298.00±394.56[^b^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                   4,262.00±106.04[^b^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                               314.33±19.92[^b^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  346.00±43.88[^ab^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}   133.33±31.79[^bc^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}   140.00±5.77[^bc^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln+GlyGln (2.0+2.0 mM)   4,787.33±140.60[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                   5,089.66±74.06[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                449.00±39.84[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  391.33±27.55[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    120.00±11.56[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    110.00±17.32[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}
  Gln+Glu (1.0+1.0 mM)         1,960.33±121.64[^e^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                   1,941.66±54.02[^d^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                                180.00±17.32[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}                  174.00±13.32[^c^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}    186.67±8.82[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}     174.67±8.84[^a^](#tfn7-ajas-26-4-501-7){ref-type="table-fn"}

Within a column, values with different letters (a--e) are significantly different (p\<0.05).

n: number of oocytes, five replicates.

Maturation (44 h incubation period in IVM).

Fertilization (6 h incubation period after IVM).

Mean±SEM obtained from the average of each replicate.

###### 

Effects of glutamine (Gln), glutamic acid (Glu), L-alayl-L-glutamine (AlaGln), L-glycyl-L-glutamine (GlyGln) and their combinations on the development of porcine embryos

  Treatment                    n     Percentages of embryo development (mean±SEM)[^2^](#tfn15-ajas-26-4-501-7){ref-type="table-fn"}                                                                                                                                                  
  ---------------------------- ----- ------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------- ---------------------------------------------------------------------- ----------------------------------------------------------------------
  Control (0)                  173   \(122\) 71.00±1.73[^d^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(111\) 64.30±1.32[^cd^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}   \(61\) 35.23±1.75[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(42\) 24.00±1.72[^cd^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}
  Gln (1.0 mM)                 160   \(112\) 70.00±2.89[^d^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(106\) 66.23±1.18[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(55\) 34.10±1.16[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(40\) 25.13±1.74[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}
  Glu (1.0 mM)                 170   \(121\) 72.00±1.15[^d^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(107\) 63.20±2.89[^cd^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}   \(61\) 36.26±1.181[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}   \(37\) 22.00±2.31[^d^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln (2.0 mM)              154   \(117\) 76.00±2.31[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(117\) 75.30±1.76[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(70\) 46.23±0.91[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(48\) 31.63±2.34[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}
  GlyGln (2.0 mM)              153   \(122\) 79.00±2.31[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(119\) 77.93±2.45[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(73\) 48.02±1.21[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(47\) 31.36±1.77[^b^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln+GlyGln (2.0+2.0 mM)   203   \(167\) 82.16±1.17[^a^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(166\) 82.13±1.16[^a^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    (108)53.03±1.16[^a^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}      \(83\) 41.23±1.18[^a^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}
  Gln+Glu (1.0+1.0 mM)         174   \(124\) 72.20±1.17[^d^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}                             \(108\) 62.23±1.18[^d^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(60\) 34.60±0.95[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}    \(45\) 25.83±0.83[^c^](#tfn12-ajas-26-4-501-7){ref-type="table-fn"}

Within a column, values with different letters (a--d) are significantly different (p\<0.05).

n: number of embryos, five replicates.

Embryo development calculated from cleaved embryos.

Mean±SEM obtained from the average percentage of each replicate.

###### 

The rates of incorporation and oxidation of ^14^C(U)-glucose, and the accumulation of ammonia upon treatment with glutamine (Gln), glutamic acid (Glu), L-alayl-L-glutamine (AlaGln), L-glycyl-L-glutamine (GlyGln) and their combinations in medium on the 2-cell and blastocyst stages

  Treatment n (25)             Incorporation of ^14^C(U)-glucose (cpm/embryo)                      Oxidation of ^14^C (U)-glucose (cpm/embryo)                         Ammonia concentration (μM)                                                                                                                                                                             
  ---------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ----------------------------------------------------------------- ----------------------------------------------------------------- ------------------------------------------------------------------ -----------------------------------------------------------------
  Control (0)                  1,283.67±157.33[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   1,513.33±170.33[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   230.00±17.32[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    490.00±23.09[^cd^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   160.00±11.56[^ab^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    171.67±6.01[^ab^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}
  Gln (1.0 mM)                 1,182.02±136.83[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   1,338.00±118.62[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   323.00±12.70[^bc^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   450.66±22.81[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    173.33±12.01[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}     178.33±9.28[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}
  Glu (1.0 mM)                 1,231.00±232.69[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   1,309.00±230.94[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   341.66±17.64[^bc^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   451.33±18.05[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    170.00±17.32[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}     176.66±14.53[^ab^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln (2.0 mM)              2,163.00±144.63[^b^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   2,330.66±179.98[^b^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   374.00±43.47[^b^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    550.00±17.32[^b^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    120.00±5.77[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}      140.00±11.56[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}
  GlyGln (2.0 mM)              2,022.00±112.32[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   2,528.33±221.82[^b^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   373.03±53.69[^b^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    540.00±23.09[^bc^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   130.00±5.77[^bc^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}     150.00±11.56[^bc^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln+GlyGln (2.0+2.0 mM)   2,638.33±123.16[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   3,539.67±168.18[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   589.00±16.74[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    741.00±12.12[^a^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    70.00±11.56[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}      100.00±11.54[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}
  Gln+Glu (1.0+1.0 mM)         1,229.00±125.28[^d^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   1,398.00±285.79[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   295.00±28.87[^c^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}    487.00±50.23[^cd^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   150.00±11.56[^abc^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}   170.00±15.28[^ab^](#tfn16-ajas-26-4-501-7){ref-type="table-fn"}

Within a column, values with different letters (a--d) are significantly different (p\<0.05).

n: number of embryos, five replicates. Mean±SEM obtained from the average of each replicate.

###### 

Effects of glutamine (Gln), glutamic acid (Glu), L-alayl-L-glutamine (AlaGln), L-glycyl-L-glutamine (GlyGln) and their combinations on blastocyst cell number

  Treatment                    Cell numbers (mean±SEM)                                                                                                        
  ---------------------------- -------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------
  Control (0)                  14.00±1.15[^f^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   22.00±2.31[^cd^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   36.00±3.46[^cd^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}
  Gln (1.0 mM)                 17.20±1.17[^d^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   21.00±1.73[^de^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   38.20±2.90[^c^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}
  Glu (1.0 mM)                 16.86±1.16[^d^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   23.03±1.73[^c^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}    39.89±2.89[^c^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln (2.0 mM)              25.20±1.74[^b^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   34.00±1.15[^b^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}    59.20±2.89[^b^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}
  GlyGln (2.0 mM)              23.00±1.73[^c^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   35.07±1.73[^b^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}    58.07±3.46[^b^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}
  AlaGln+GlyGln (2.0+2.0 mM)   27.33±1.45[^a^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   39.00±1.15[^a^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}    66.33±2.60[^a^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}
  Gln+Glu (1.0+1.0 mM)         15.00±1.55[^e^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}   20.00±1.15[^e^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}    35.00±2.70[^d^](#tfn19-ajas-26-4-501-7){ref-type="table-fn"}

Values shown were obtained based on 30 embryos from three replicates.

Within the same column, values with different superscript letters (a--f) are significantly different (p\<0.05).
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